Literature DB >> 12700941

Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation.

Radek Spisek1, Gwenola Bougras, Frederic Ebstein, Delphine Masse, Khaled Meflah, Dorian McIlroy, Marc Gregoire.   

Abstract

Dendritic cells (DC) are activated by pathogens, cytokines and activated T cells. We investigated the impact of a transient initial DC stimulation on the kinetics of maturation using a combination of double-stranded RNA and TNFalpha and subsequent restimulation by T cell-derived stimuli. Transient stimulation of DC was sufficient to start an irreversible program of phenotypic maturation which proceeded in the absence of the initial stimulus. Transiently stimulated DC secreted lower amounts of IL-12 during the 48-h period of the first stimulation than cells activated for 48 h. Although both DC preparations expressed the same level of maturation-associated markers at 48 h, DC stimulated for shorter periods preserved higher sensitivity to boosting upon subsequent stimulation by T cell-derived signals. We showed that DC initially stimulated for shorter periods were more potent stimulators of T lymphocytes and they induced a more polarized Th1 response. These results indicate that short exposure of DC to maturation stimuli enables an efficient defensive immune response induction by differentially regulating phenotypic maturation and cytokine production of DC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700941     DOI: 10.1007/s00262-002-0368-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  6 in total

1.  Dendritic cells post-maturation are reprogrammed with heightened IFN-gamma and IL-10.

Authors:  Chang-Qing Xia; Ruihua Peng; Mani Annamalai; Michael J Clare-Salzler
Journal:  Biochem Biophys Res Commun       Date:  2006-12-06       Impact factor: 3.575

2.  Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner C Greene
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.

Authors:  A Escobar; M López; A Serrano; M Ramirez; C Pérez; A Aguirre; R González; J Alfaro; M Larrondo; M Fodor; C Ferrada; F Salazar-Onfray
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy.

Authors:  Katerina Vavrova; Petra Vrabcova; Dominik Filipp; Jirina Bartunkova; Rudolf Horvath
Journal:  Med Oncol       Date:  2016-11-03       Impact factor: 3.064

5.  Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials.

Authors:  Jitka Fučíková; Daniela Rožková; Hana Ulčová; Vít Budinský; Klára Sochorová; Kateřina Pokorná; Jiřina Bartůňková; Radek Špíšek
Journal:  J Transl Med       Date:  2011-12-30       Impact factor: 5.531

Review 6.  Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.

Authors:  Katerina Kalkusova; Sindija Smite; Elea Darras; Pavla Taborska; Dmitry Stakheev; Luca Vannucci; Jirina Bartunkova; Daniel Smrz
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.